VEA
RARX
Virtus ETF Advisers’s Ra Pharmaceuticals, Inc. Common Stock RARX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-7,612
| Closed | -$365K | – | 498 |
|
|
2020
Q1 | $365K | Sell |
7,612
-1,123
| -13% | -$53.8K | 0.15% | 203 |
|
|
2019
Q4 | $410K | Sell |
8,735
-3,146
| -26% | -$148K | 0.07% | 246 |
|
|
2019
Q3 | $281K | Sell |
11,881
-662
| -5% | -$15.7K | 0.06% | 203 |
|
|
2019
Q2 | $377K | Sell |
12,543
-3,645
| -23% | -$110K | 0.08% | 193 |
|
|
2019
Q1 | $363K | Sell |
16,188
-1,662
| -9% | -$37.3K | 0.77% | 44 |
|
|
2018
Q4 | $325K | Buy |
+17,850
| New | +$325K | 0.06% | 93 |
|